Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Camilla Zecchetto
Observed names:
C Zecchetto,
C. Zecchetto,
Camilla Zechetto,
Zecchetto, Camilla
Institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona
Observed institutions:
University of Verona,
Fudan University Shanghai Cancer Center,
Azienda Ospedaliera Universitaria Integrata Verona
ORCID:
0000-0002-1028-6431
Observed ORCID:
0000-0002-1028-6431
OpenAlex ID:
A5086805194
Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib
2020
·
Ian M. Silverman
, Antoine Hollebecque
, et al.
·
Cancer Discovery
·
313
PDF
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
2021
·
Davide Melisi
, Do-Youn Oh
, et al.
·
Journal for ImmunoTherapy of Cancer
·
233
PDF
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
2018
·
Carmine Carbone
, Geny Piro
, et al.
·
International Journal of Molecular Sciences
·
228
PDF
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
2019
·
Laura Maggino
, Giuseppe Malleo
, et al.
·
JAMA Surgery
·
153
PDF
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
2021
·
Valeria Merz
, Marina Gaule
, et al.
·
Frontiers in Oncology
·
81
PDF
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer
2019
·
Raffaela Santoro
, Marco Zanotto
, et al.
·
Molecular Cancer Therapeutics
·
64
PDF
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
2017
·
Geny Piro
, Francesca Simionato
, et al.
·
OncoImmunology
·
59
PDF
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients
2017
·
Carmine Carbone
, Geny Piro
, et al.
·
Clinical Cancer Research
·
51
PDF
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling
2017
·
C Carbone
, G Piro
, et al.
·
International Journal of Obesity
·
46
PDF
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial
2020
·
Valeria Merz
, Camilla Zecchetto
, et al.
·
Therapeutic Advances in Medical Oncology
·
44
PDF
Pemigatinib, a Potent Inhibitor of FGFRs for the Treatment of Cholangiocarcinoma
2020
·
Valeria Merz
, Camilla Zecchetto
, et al.
·
Future Oncology
·
42
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma
2023
·
Silvia Pietrobono
, Fabio Sabbadini
, et al.
·
Cancer Research
·
37
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic
2020
·
Serena Zuliani
, Ilaria Zampiva
, et al.
·
European Journal of Cancer
·
32
PDF
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
2020
·
Valeria Merz
, Camilla Zecchetto
, et al.
·
Clinical Cancer Research
·
30
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
2022
·
Marina Gaule
, Camilla Pesoni
, et al.
·
JCO Precision Oncology
·
19
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma
2023
·
Letizia Procaccio
, Valeria Merz
, et al.
·
Cancer Medicine
·
18
PDF
CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages
2024
·
Silvia Pietrobono
, Monica Bertolini
, et al.
·
npj Precision Oncology
·
16
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial
2023
·
Davide Melisi
, Camilla Zecchetto
, et al.
·
European Journal of Cancer
·
14
PDF
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial
2020
·
Francesca Simionato
, Camilla Zecchetto
, et al.
·
Therapeutic Advances in Medical Oncology
·
14
PDF
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer
2019
·
Alessandro Cavaliere
, Valeria Merz
, et al.
·
Journal of the Korean Gastric Cancer Association
·
13
PDF
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients
2020
·
Valeria Merz
, Alessandro Cavaliere
, et al.
·
Cancers
·
12
PDF
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear
2024
·
Davide Melisi
, Simona Casalino
, et al.
·
Therapeutic Advances in Medical Oncology
·
10
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer
2023
·
Maria Bencivenga
, Lorena Torroni
, et al.
·
Journal of Personalized Medicine
·
9
PDF
Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers
2023
·
Simone Conci
, Giovanni Catalano
, et al.
·
International Journal of Medical Sciences
·
9
PDF
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients
2021
·
Davide Melisi
, Alessandro Cavaliere
, et al.
·
Pancreatology
·
9
Show more works
View as search
Works count:
117
Citation count:
1,613
H-index:
16
I10-index:
22
Year
Topic
Type